Renninger Robert (CIK 2037968) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy LONA (3,900 shares), Sell LONA (906 shares), Buy ATHA (1,000 shares), Buy ATHA (1,236 shares), Sell ATHA (297 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | LeonaBio, Inc. (LONA) | CHIEF FINANCIAL OFFICER | Buy | 3,900 | $0 |
| 2026-03-05 | LeonaBio, Inc. (LONA) | CHIEF FINANCIAL OFFICER | Sell | 906 | $4,865 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | Chief Financial Officer | Buy | 1,000 | $2,310 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | Chief Financial Officer | Buy | 1,236 | $0 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | Chief Financial Officer | Sell | 297 | $2,043 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | SVP, Finance and Accounting | Buy | 10,000 | $2,300 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | SVP, Finance and Accounting | Buy | 12,359 | $0 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | SVP, Finance and Accounting | Sell | 2,897 | $840 |
Source: SEC Form 4 filings · as of 2026-03-05